文献速递淋巴瘤

经典霍奇金淋巴瘤中TNFAIP3缺失状态及其与Epstein-Barr病毒的关系

[TNFAIP3 deletion status in classical Hodgkin lymphoma and its relation to Epstein-Barr virus].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2016-01-01

研究54例经典霍奇金淋巴瘤(CHL)患者石蜡标本,用组织芯片、免疫组化、原位杂交和荧光原位杂交检测EBV感染、A20蛋白表达及TNFAIP3缺失。结果显示EBV阳性率25.9%(14/54),A20表达缺失27.8%(15/54),TNFAIP3缺失20.4%(10/49),两种方法结果不一致,且与EBV感染无显著相关性(P>0.05)。

要点

  • CHL中EBV感染率为25.9%(14/54),LMP-1与EBER1/2检测符合率100%。
  • A20表达缺失见于27.8%(15/54)病例,TNFAIP3缺失见于20.4%(10/49)病例。
  • TNFAIP3缺失伴A20完全丢失仅1例,两种方法结果不一致可能与技术因素有关。

核心结论

  • EBV阳性和阴性CHL病例均存在TNFAIP3基因和(或)A20蛋白表达丢失。
  • 免疫组化检测A20表达不能证实FISH检测的TNFAIP3缺失,可能与技术因素有关。

研究设计与样本

  • 收集54例经典霍奇金淋巴瘤(CHL)患者的福尔马林固定石蜡包埋组织块,制作组织芯片。
  • 采用免疫组化检测LMP-1、原位杂交检测EBER1/2以明确EBV感染状态。
  • 采用位点特异性间期荧光原位杂交(FISH)检测TNFAIP3拷贝数改变,免疫组化检测A20蛋白表达。
  • 使用SPSS17.0统计学软件包进行数据分析。

主要发现

  • LMP-1和EBER1/2阳性率均为25.9%(14/54),两者符合率为100%。
  • 27.8%(15/54)的标本存在A20表达丢失。
  • 49例同时进行FISH分析的标本中,10例(20.4%)存在TNFAIP3缺失。
  • TNFAIP3缺失伴A20免疫反应完全丢失仅1例。
  • EBV阳性与阴性病例间A20表达丢失或TNFAIP3缺失频率比较均无显著差异(P>0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the TNFAIP3/A20 abnormalities and its association with Epstein-Barr virus (EBV) in classical Hodgkin lymphoma (CHL). Methods: Formalin-fixed, paraffinembedded tissue blocks of 54 CHL patients were collected and subjected to the construction of tissue microarray (TMA) for further analyses. EBV status was evaluated by in situ hybridization (ISH) for EBER1/2 and immunohistochemistry (IHC) with anti-LMP-1 antibody. Fluorescence in situ hybridization (FISH) and IHC were performed to determine the copy number alterations of TNFAIP3 and A20 protein expression respectively. Results: The concordance rate of IHC for LMP-1 and ISH for EBER1/2 was100%, and 25.9% (14/54) cases were identified with EBV infection. Immunohistochemistry analysis demonstrated 27.8% (15/54) cases with A20 expression deficiency. Of the 54 cases tested for A20 expression, 49 cases were simultaneously analyzed by FISH, which showed 10 (20.4% ) cases harboring TNFAIP3 deletion. However, discrepancy was observed between the results of A20 by IHC and TNFAIP3 deletion by FISH. Only 1 case with TNFAIP3 deletion demonstrated complete loss of A20 immunoreactivity. In addition, comparison of the frequency of either A20 expression loss or TNFAIP3 deletion between EBV-positive and-negative cases did not reveal any significance (P>0.05). Conclusion: TNFAIP3 deletion could be observed in both EBV-positive and - negative CHL cases. A20 expression by IHC could not confirm TNFAIP3 deletion by FISH, which might be related to the technical issues. 目的: 研究经典霍奇金淋巴瘤(CHL)中肿瘤坏死因子α诱导蛋白3(TNFAIP3)基因及其编码的A20蛋白表达情况,并分析其与Epstein-Barr病毒(EBV)感染的相关性。 方法: 收集54例CHL患者的病理标本及临床资料,选取肿瘤细胞丰富区制作组织芯片。应用免疫组织化学染色法检测EBV编码的潜伏膜蛋白1(LMP-1),原位杂交法检测EBV编码的RNA(EBER1/2)以明确EBV感染状态。使用位点特异性间期荧光原位杂交(FISH)法检测TNFAIP3基因表达,免疫组织化学染色法检测A20蛋白表达。使用SPSS17.0统计学软件包进行数据分析。 结果: LMP-1、EBER1/2阳性率均为25.9%(14/54),两者符合率为100%。27.8%(15/54)的标本存在A20表达丢失,20.4%(10/49)的标本存在TNFAIP3杂合或纯合缺失。两种方法的检测结果显示存在明显不一致,TNFAIP3缺失伴A20丢失仅有1例。此外,EBV感染阴性与A20丢失及TNFAIP3缺失无相关性(P>0.05)。 结论: EBV阳性和阴性CHL病例均存在TNFAIP3基因和(或)A20蛋白表达丢失。FISH和免疫组织化学染色两种方法结果不一致,可能与技术因素有关。

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Shi YF, Gao ZF, Liu CL, et al. [TNFAIP3 deletion status in classical Hodgkin lymphoma and its relation to Epstein-Barr virus]. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 28088970. doi:10.3760/cma.j.issn.0253-2727.2016.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。